Modi Naturals Subsidiary Expands Ethanol Capacity in Chhattisgarh

Modi Naturals' subsidiary, Modi Biotech Private Limited, has commenced commercial operations at its expanded ethanol plant in Chhattisgarh. The facility's production capacity has nearly doubled to 282 KLPD, an increase of 152 KLPD from its previous level.

What just happened

Modi Naturals Limited announced that its wholly-owned subsidiary, Modi Biotech Private Limited, has started commercial operations at its expanded ethanol plant in Chhattisgarh. The facility's production capacity has increased from 130 KLPD to 282 KLPD.

The expansion is expected to improve operational efficiencies and boost output, aligning with the company's strategic goals and supporting the Government of India's Ethanol Blended Petrol Programme (EBPP).

Why this matters

This doubling of ethanol production capacity is a key development for Modi Naturals. It positions the company to capitalize on rising demand for biofuels, driven by the government's push for cleaner energy and reduced dependence on fossil fuels. The EBPP provides strong policy support for such expansions.

Increased output from the Chhattisgarh plant is expected to boost the company's revenue and profitability, strengthening its role in India's renewable energy sector.

The backstory

Modi Biotech Private Limited, established in April 2021, serves as Modi Naturals' division for grain-based ethanol manufacturing. Previous reports detailed an expansion project with an investment of approximately ₹100 crore to add 180 KLPD, aiming for a total capacity of 310 KLD, expected within 8-10 months. This announcement confirms the operationalization of that expansion.

Launched in 2003, the Government of India's Ethanol Blended Petrol (EBP) Programme aims to increase ethanol blending with petrol, reducing oil imports and curbing emissions.

What changes now

• Enhanced Production Volume: Modi Naturals can now produce nearly double the amount of ethanol, meeting higher market demand.
• Improved Operational Efficiency: The expanded plant is expected to run more efficiently, potentially lowering per-unit production costs.
• Revenue Growth Potential: Higher output offers a direct path to increased revenue from ethanol sales.
• Strategic Alignment: The expansion supports India's national biofuel policy and energy security goals.
• Subsidiary's Role: Modi Biotech strengthens its position as a key ethanol producer in the region.

Risks to watch

Modi Naturals Limited has faced scrutiny over its financial reporting. CARE Ratings placed the company under the 'issuer non-cooperating' category in June 2024 for failing to provide necessary information for rating monitoring. While this expansion is positive, investors should remain vigilant regarding corporate governance and financial transparency.

Peer comparison

Modi Naturals' 282 KLPD capacity places it among other significant Indian ethanol producers. Competitors like Balrampur Chini Mills exceed 1000 KLPD, Dhampur Sugar Mills operates around 350 KLPD, and EID Parry is also a major contributor. Modi Naturals must now focus on leveraging its increased capacity within its specific market.

Program Context

• The Indian government aims to achieve 20% ethanol blending in petrol (E20) by 2025, a target that drives demand for domestic ethanol production.
• Previously, Modi Biotech operated with a capacity of 130 KLPD.

What to track next

• Production ramp-up: Monitor the plant's actual output and its ability to reach optimal capacity consistently.
• Financial performance: Observe the contribution of the ethanol division to Modi Naturals' overall revenue and profitability.
• Government policy: Track any further policy changes or incentives related to the Ethanol Blended Petrol Programme.
• Raw material sourcing: Ensure stable and cost-effective sourcing of grains for the distillery.
• Order book and off-take: Keep an eye on further orders secured from Oil Marketing Companies (OMCs).